Jushi Holdings (JUSHF) Non-Current Debt (2021 - 2026)
Jushi Holdings (JUSHF) reported Non-Current Debt of $218.5 million for Q1 2026, up 13.16% year-over-year from $193.1 million in Q1 2025, and up 9.67% quarter-over-quarter from $199.2 million in Q4 2025.
Jushi Holdings (JUSHF) Non-Current Debt (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Non-Current Debt data on file, last reported at $218.5 million in Q1 2026.
- Non-Current Debt for Q1 2026 came in at $218.5 million, up 13.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $218.5 million (up 13.16% YoY), and the FY2025 annual result was $199.2 million, up 8.58% from the prior year.
- Non-Current Debt climbed to $218.5 million in Q1 2026 per JUSHF's latest filing, from $199.2 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $218.5 million in Q1 2026 and troughed at $61.9 million in Q3 2022.
- A 5-year average of $167.9 million and a median of $182.5 million in 2023 frame the typical range for Non-Current Debt.
- On a YoY basis, Non-Current Debt climbed as much as 184.94% in 2023 and fell as far as 30.19% in 2023.
- A 5-year view of Non-Current Debt shows it stood at $180.6 million in 2022, then plunged by 30.19% to $126.0 million in 2023, then surged by 45.55% to $183.4 million in 2024, then rose by 8.58% to $199.2 million in 2025, then advanced by 9.67% to $218.5 million in 2026.
- Business Quant data shows JUSHF's Non-Current Debt at $218.5 million in Q1 2026, $199.2 million in Q4 2025, and $155.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 218.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218.47 Mn |
| Mar 31, 2026 | 218.47 Mn |
| Dec 31, 2025 | 199.20 Mn |
| Dec 31, 2025 | 199.20 Mn |
| Sep 30, 2025 | 155.69 Mn |
| Sep 30, 2025 | 155.69 Mn |
| Jun 30, 2025 | 192.83 Mn |
| Jun 30, 2025 | 192.83 Mn |
| Mar 31, 2025 | 193.05 Mn |
| Mar 31, 2025 | 193.05 Mn |
| Dec 31, 2024 | 183.45 Mn |
| Dec 31, 2024 | 183.45 Mn |
| Sep 30, 2024 | 183.71 Mn |
| Sep 30, 2024 | 183.71 Mn |
| Jun 30, 2024 | 192.48 Mn |
| Jun 30, 2024 | 192.48 Mn |
| Mar 31, 2024 | 127.18 Mn |
| Mar 31, 2024 | 127.18 Mn |
| Dec 31, 2023 | 126.04 Mn |
| Dec 31, 2023 | 126.04 Mn |